Liraglutide Guide Liraglutide is another GLP-1-based treatment that supports weight loss by slowing digestion and increasing satiety after meals
Retatrutide in Type 2 Diabetes Recent clinical research on retatrutide, a novel triple-hormone receptor agonist, has shown promising results for people with type 2 diabetes
Whats Actually Happening In Your Stomach About one in eight adults in the US now takes a GLP-1 medication, according to the American Society of Anesthesiologists, which is part of why this conversation has become routine pre-op intake rather than a rare exception
This wide array of potential applications makes it a compelling subject for continued scientific inquiry
Healthcare professionals should be aware of this potential side effect and enquire about taste changes during follow-up consultations, particularly if patients report reduced appetite or difficulty maintaining adequate nutrition
Coverage may be better for people with diabetes